Miller Steve
- SEC CIK
- 0001402535
No open-market purchases or sales filed in the past year.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Chief Op. & Scientific Officeras of Jul 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Miller Steve as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −41.0K | $6.09 | −$249.5K | −5.5%701.7K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −80.0K | $5.56 | −$444.8K | −9.7%741.7K after | |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −118.6K | $13.56 | −$1.61M | −13.5%761.7K after | |
| Aug 19, 2022 (view filing) | Aug 18 | 1 day | Miller SteveChief Operating Officer | SSaleCommon Stock, par value $0.001 per share | −31.4K | $13.43 | −$422.0K | −4.0%761.7K after | |
| Sep 15, 2022 (view filing) | Sep 13 | 2 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −107.9K | $16.91 | −$1.82M | −14.2%653.8K after | 3 lots |
| Nov 23, 2022 (view filing) | Nov 21-23 | 2 days | Miller SteveChief Operating Officer | SSaleCommon stock, par value $0.001 per share | −100.0K | $15.69 | −$1.57M | −15.3%553.8K after | 2 lots |
| Dec 7, 2023 (view filing) | Dec 5 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −40.0K | $14.24 | −$569.6K | −5.8%647.5K after | |
| Aug 22, 2024 (view filing) | Aug 20 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −150.0K | $20.35 | −$3.05M | −18.2%675.1K after | 3 lots |
| Dec 11, 2024 (view filing) | Dec 10 | 1 day | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −50.0K | $21.93 | −$1.10M | −6.8%687.0K after | |
| Aug 28, 2025 (view filing) | Aug 26 | 2 days | Miller SteveChief Op. & Scientific Officer | SSaleCommon stock, par value $0.001 per share | −115.0K | $20.28 | −$2.33M | −10.8%949.7K after |